PaulFRiderJr.MD

Colon & Rectal Surgery • Mobile, AL

Professor, Surgery, University of South Alabama College of Medicine Specializing in diagnosing and treatment of anorectal and colorectal conditions and cancers

Join to view full profile

Dr. Rider is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rider's full profile

Already have an account?

Office
2451 University Hospital Drive
Suite 101
Mobile, AL 36617
Phone+1 251-445-8282

Fax+1 251-445-8281

Summary

Dr. Paul F. Rider is a Colorectal Surgeon, specializing in diagnosing and treatment of anorectal and colorectal conditions and cancers. He completed a Surgery Fellowship at Ochsner Health System in Jefferson, LA. He is an Associate Professor of Surgery at the USA College of Medicine.

Paul Rider, M.D., F.A.C.S., F.A.S.C.R.S. | USA Health

TAK-954-2004: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous T

Education & Training

Ochsner Clinic FoundationResidency, Colon and Rectal Surgery, 2008 - 2009
University of Kentucky College of MedicineResidency, Surgery, 2003 - 2008
University of South Alabama College of MedicineClass of 2003

Certifications & Licensure

AL State Medical License 2009 - 2025
GA State Medical License 2015 - 2020
LA State Medical License 2008 - 2009
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
American Board of Surgery Surgery

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACS) American College of Surgeons

Clinical Trials

Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery Start of enrollment: 2013 Jan 10
Completed
Phase 3
A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60 Start of enrollment: 2014 Oct 01
Terminated
Phase 1, Phase 2

Publications & Presentations

PubMed

4 citations
The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcin...
Moh’d M. Khushman, Pranitha Prodduturvar, Wadad Mneimneh, Valeria Dal Zotto, Shalla Akbar
Oncotarget. 2021-07-20
18 citations
Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo ...
Timothy L Beard, Cathy Michalsky, Keith A. Candiotti, Paul Rider, Linda Wase
Pain and Therapy. 2021-06-01
15 citations
Low Incidence of Postoperative Respiratory Depression with Oliceridine Compared to Morphine: A Retrospective Chart Analysis
Sergio D. Bergese, Richard D Berkowitz, Paul Rider, Martin Ladouceur, Suzanne Griffith
Pain Research & Management. 2020-10-24

Professional Memberships

American College of Surgeons - ACS
Member